Among these biomarkers, carcinoembryonic antigen (CEA), a glycoprotein with a molecular weight of approximately 180–200 kDa, has emerged as one of the most clinically significant markers, particularly for colorectal, gastric, and breast carcinomas [2]. The gene discussed is CEACAM5; the disease is breast carcinoma.